CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 39 filers reported holding CITIUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $29 | -6.5% | 23,846 | -38.9% | 0.00% | -50.0% |
| Q4 2022 | $31 | -100.0% | 39,005 | -52.1% | 0.00% | -33.3% |
| Q2 2022 | $75,000 | +8.7% | 81,410 | +313.0% | 0.01% | -14.3% |
| Q2 2021 | $69,000 | -54.3% | 19,713 | -86.7% | 0.01% | -56.2% |
| Q4 2020 | $151,000 | +26.9% | 147,663 | +29.3% | 0.02% | -20.0% |
| Q3 2020 | $119,000 | +14.4% | 114,223 | +24.4% | 0.02% | +66.7% |
| Q2 2020 | $104,000 | +700.0% | 91,793 | +455.7% | 0.01% | +1100.0% |
| Q3 2019 | $13,000 | – | 16,519 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 314,000 | $559,000 | 0.11% |
| Inspire Advisors, LLC | 110,787 | $197,000 | 0.07% |
| Horst & Graben Wealth Management LLC | 49,590 | $88,000 | 0.03% |
| Freed Investment Group | 14,600 | $26,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 57,465 | $102,000 | 0.02% |
| Miller Investment Management, LP | 50,000 | $89,000 | 0.02% |
| LMR Partners LLP | 63,950 | $114,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 50,356 | $90,000 | 0.00% |
| Renaissance Technologies | 989,096 | $1,761,000 | 0.00% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 20,000 | $36,000 | 0.00% |